Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors

Currently, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has infected people among all countries and is a pandemic as declared by the World Health Organization (WHO). SARS-CoVID-2 main protease is one of the therapeutic drug targets that has been shown to reduce virus replication, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalhotra, Poonam, Chittepu, Veera C. S. R., Osorio-Revilla, Guillermo, Gallardo-Velazquez, Tzayhri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916619/
https://www.ncbi.nlm.nih.gov/pubmed/33578831
http://dx.doi.org/10.3390/molecules26040936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916619/
https://www.ncbi.nlm.nih.gov/pubmed/33578831
http://dx.doi.org/10.3390/molecules26040936

Ejemplares similares